Abstract:Background Despite much improvement in the treatment for acute lymphoblastic leukemia (ALL), childhood ALLs with MLL -rearrangement ( MLL -r) still have inferior dismal prognosis. Thus, defining mechanisms underlying MLL -r ALL maintenance is critical for developing effective therapy. Methods GSE13159 and GSE28497 were selected via the Oncomine website. Differentially expressed genes (DEGs) between MLL -r ALLs and normal samples were identified by R software. Next, functional enrichment analysis of these DEGs were carried out by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). Then, the key hub genes and modules were identified by Weighted Gene Co-expression Network Analysis (WGCNA). Therapeutically Applicable Research to Generate Effective Treatments (TARGET) ALL (Phase I) of UCSC Xena analysis, qPCR, and Kaplan-Meier analysis were conducted for validating the expression of key hub genes from bone marrow cells of childhood ALL patients or ALL cell lines. Results A total of 1,045 DEGs were identified from GSE13159 and GSE28497. Through GO, KEGG, GSEA, and STRING analysis, we demonstrated that MLL -r ALLs were upregulating “nucleosome assembly” and “B cell receptor signal pathway” genes or proteins. WGCNA analysis found 18 gene modules using hierarchical clustering between MLL -r ALLs and normal. The Venn diagram was used to filter the 98 hub genes found in the key module with the 1,045 DEGs. We identified 18 hub genes from this process, 9 of which were found to be correlated with MLL -r status, using the UCSC Xena analysis. By using qPCR, we validated these 9 hub key genes to be upregulated in the MLL -r ALLs (RS4;11 and SEM) compared to the non- MLL -r ALL (RCH-ACV) cell lines. Three of these genes, BCL11A , GLT8D1 and NCBP2, were shown to be increased in MLL -r ALL patient bone marrows compared to the non- MLL -r ALL patient. Finally, Kaplan–Meier analysis indicated that childhood ALL patients with high BCL11A expression had significantly poor overall survival. Conclusion These findings suggest that upregulated BCL11A gene expression in childhood ALLs may lead to MLL -r ALL development and BCL11A represents a new potential therapeutic target for childhood MLL -r ALL.

SOX11 Regulates the Pro-Apoptosis Signal Pathway and Predicts a Favorable Prognosis of Mantle Cell Lymphoma.

SOX11-negative Mantle Cell Lymphoma

SOX11: friend or foe in tumor prevention and carcinogenesis?

SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma

SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma

Prognostic significance and biological implications of SM-like genes in mantle cell lymphoma

Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2(+) diffuse large B-cell lymphomas

SOX9+ malignant cells define a poor prognosis subtype of Glioma with tumor-associated macrophage recruitment

Systematic Investigation of the Multifaceted Role of SOX11 in Cancer.

Paired-Box 5 Positivity Related to High MIPI Score Predicts Shorter Overall Survival in Mantle Cell Lymphoma Patients

The Expression of SOX1 1, Cyclin D1, Cyclin D2 and Cyclin D3 in B-cell Lymphocytic Proliferative Diseases

Exosome Complex Genes Mediate RNA Degradation and Predict Survival in Mantle Cell Lymphoma

Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma

BCL11A Expression Worsens the Prognosis of DLBCL and Its Co-Expression with C-MYC Predicts Poor Survival

SOX13-mediated transcription of LRP11 enhances malignant properties of tumor cells and CD8+ T cell inactivation in breast cancer through the β-catenin/PD-L1 axis

The Metastasis Suppressor SOX11 is an Independent Prognostic Factor for Improved Survival in Gastric Cancer

SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL

SOX12 Contributes to the Activation of the JAK2/STAT3 Pathway and Malignant Transformation of Esophageal Squamous Cell Carcinoma

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features

Up-Regulation of Fbxw11 and Its Promotional Effect on Proliferation in Lymphocytic Leukemia